Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 4, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2009. Q3 2009 Summary --------------- - Total revenue...
-
Nov 3, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Dr. William Claypool, M.D., has been appointed to its Board of Directors. Since October 2008, Dr. Claypool has been a Senior Partner at...
-
Nov 2, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or the "Company") today announced that Purdue Pharma Products L.P. and Napp Pharmaceutical Group Ltd. have filed a complaint against Cipher in the...
-
Oct 26, 2009
- Third quarter financial results to be released November 4, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 26 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Oct 7, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has enrolled the first patient in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...